Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Menard

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of the American Heart Association|May 22, 2025
Association of Lipoprotein(a) With Major Adverse Limb Events and All-Cause Mortality Following Revascularization for Chronic Limb-Threatening Ischemia: A Substudy of the BEST-CLI TrialAlexander E Sullivan, Shi Huang, Suman Kundu, et al.
Circulation. Cardiovascular Interventions|March 18, 2025
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening IschemiaMichael S Conte, Alik Farber, Andrew Barleben, et al.
The Journal of Vascular Access|November 23, 2012
A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creationEric K Peden, David B Leeser, Bradley S Dixon, et al.
Journal of Vascular Surgery|June 15, 2023
Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI TrialJeffrey J Siracuse, Alik Farber, Matthew T Menard, et al.
Journal of the American Heart Association|July 13, 2016
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) TrialMatthew T Menard, Alik Farber, Susan F Assmann, et al.
Journal of Vascular Surgery|November 29, 2025
Contemporary outcomes of lower extremity vein bypass for chronic limb-threatening ischemia based on a post hoc comparison of the BEST-CLI and PREVENT III multicenter prospective randomized controlled trialsMohamad A Hussain, Ali A Khan, Matthew T Menard, et al.
Journal of Vascular Surgery|January 23, 2025
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trialMahmoud B Malas, Mohammed Hamouda, Alik Farber, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemiaZafar Zafari, Mehdi Najafzadeh, Mufaddal Mahesri, et al.
Journal of Vascular Surgery|May 18, 2023
Baseline modern medical management in the BEST-CLI trialMatthew T Menard, Michael R Jaff, Alik Farber, et al.
Circulation|April 10, 2024
Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With RevascularizationMatthew T Menard, Alik Farber, Richard J Powell, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of the American Heart Association|May 22, 2025
Association of Lipoprotein(a) With Major Adverse Limb Events and All-Cause Mortality Following Revascularization for Chronic Limb-Threatening Ischemia: A Substudy of the BEST-CLI TrialAlexander E Sullivan, Shi Huang, Suman Kundu, et al.
Circulation. Cardiovascular Interventions|March 18, 2025
Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening IschemiaMichael S Conte, Alik Farber, Andrew Barleben, et al.
The Journal of Vascular Access|November 23, 2012
A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creationEric K Peden, David B Leeser, Bradley S Dixon, et al.
Journal of Vascular Surgery|June 15, 2023
Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI TrialJeffrey J Siracuse, Alik Farber, Matthew T Menard, et al.
Journal of the American Heart Association|July 13, 2016
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) TrialMatthew T Menard, Alik Farber, Susan F Assmann, et al.
Journal of Vascular Surgery|November 29, 2025
Contemporary outcomes of lower extremity vein bypass for chronic limb-threatening ischemia based on a post hoc comparison of the BEST-CLI and PREVENT III multicenter prospective randomized controlled trialsMohamad A Hussain, Ali A Khan, Matthew T Menard, et al.
Journal of Vascular Surgery|January 23, 2025
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trialMahmoud B Malas, Mohammed Hamouda, Alik Farber, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemiaZafar Zafari, Mehdi Najafzadeh, Mufaddal Mahesri, et al.
Journal of Vascular Surgery|May 18, 2023
Baseline modern medical management in the BEST-CLI trialMatthew T Menard, Michael R Jaff, Alik Farber, et al.
Circulation|April 10, 2024
Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With RevascularizationMatthew T Menard, Alik Farber, Richard J Powell, et al.
Pageof 10